Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs (Q33536988)

27 July 2017

Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs (English)

1 reference

27 July 2017

Shuyun Dong

1

0 references

author name string

Sarah C Rogan

series ordinal

2

1 reference

PubMed ID

20203671

27 July 2017

Bryan L Roth

series ordinal

3

1 reference

27 July 2017

25 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

5

1 reference

27 July 2017

561-573

1 reference

27 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2009.239

27 July 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

21 January 2018

Mining the receptorome

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Predicting new molecular targets for known drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Engineered GPCRs as tools to modulate signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Engineering GPCR signaling pathways with RASSLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

A chemical-genetic approach to study G protein regulation of beta cell function in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Evolution of a second gene for beta-galactosidase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Laboratory-directed protein evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

In the light of directed evolution: pathways of adaptive protein evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Functional expression of M(1), M(3) and M(5) muscarinic acetylcholine receptors in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Drugs and valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Characterization of Gpr101 expression and G-protein coupling selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.239

21 January 2018

Identifiers

DOI

10.1038/NPROT.2009.239

1 reference

PubMed ID

20203671

Dimensions Publication ID

27 July 2017

0 references

1 reference

PubMed ID

20203671